Us Bancorp \De\ Galera Therapeutics, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.34 - $1.78 $513 - $681	-383 Reduced 11.32%	3,000 $4,000
Q2 2022 Aug 01, 2022	BUY	$1.24 - $2.39 $2,480 - $4,780	2,000 Added 144.61%	3,383 $4,000
Q1 2022 May 11, 2022	SELL	$2.01 - $4.19 $19,253 - $40,136	-9,579 Reduced 87.38%	1,383 $3,000
Q4 2021 Feb 11, 2022	BUY	$1.27 - $8.28 $486 - $3,171	383 Added 3.62%	10,962 $51,000
Q2 2021 Aug 05, 2021	BUY	$6.08 - $10.44 $64,320 - $110,444	10,579 New	10,579 $104,000

961K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $2.15M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.